Open original FDA record ↗Recall record
- FDA identifier
- Z-2239-2014
- Company in FDA record
- TomoTherapy Incorporated
- FDA classification date
- Aug 15, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Accuray is voluntarily recalling TomoTherapy H Series software versions 1.2.0, 1.2.1 and 1.2.2 (Hi-Art 4.2.0, 4.2.1 and 4.2.2). Accuray has identified potential safety issues (anomalies) with these software versions.
Source facts
- Action
- Consignees were sent an Accuray "Urgent Device Correction" letter dated July 16, 2014. The letter was addressed to TomoTherapy System Medical Physicist. The letter described the Purpose of this letter, Description of the Potential Problems, Safety Instructions and software upgrade information. For questions or concerns they can contact Accuray Customer Support at 1-877-668-8667 (USA) or 1-408-716-4700(non-USA) or customersupport@accuray.com
- Initiated
- 2014-07-17
- Root cause
- Software design
- Terminated
- 2015-09-08
- Distribution
- Worldwide Distribution-USA (nationwide) including DC and Puerto Rico and the states of US:; AL, AK, AZ, CA, CO, CT, FL, GA, HI, IL IN, IA, KS,KY, LA, MD, MA, MI, MO, MT, NE, NV, NJ, NM, NY, NC,ND, OH,OK, OR, PA, SC, SD, TX, UT, VA, WV, and WI, and the countries of AUSTRALIA, BELGIUM CANDA, CHINA, EL SALVADOR, ENGLAND, FRANCE, GERMANY, HONG KONG, INDIA, ITALY, JAPAN, KOREA, MALAYSIA, MEXICO, NETHERLANDS, PHILIPPINE, POLAND, RUSSIA, SAUDI ARABIA, SINGAPORE, SPAIN, SWEDEN, TAIWAN, THAILAND, TURKEY, and UNITED ARAB EMIRATES.
- Recall number
- Z-2239-2014
- Recall status
- Terminated
- CDRH record ID
- 129092
- FDA classified
- 2014-08-15
- Recall event number
- 68948